Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Zhanhua Haohan Pharmaceutical is a specialized manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) based in Binzhou, China. The company focuses on the development and industrial-scale production of fine chemicals used in the synthesis of antiviral and antibiotic drugs. Notably, it is a key producer of intermediates for Favipiravir, a broad-spectrum antiviral medication used for influenza and other viral infections. Operating within the Binzhou Chemical Industrial Park, the company maintains robust manufacturing capabilities and supplies chemical building blocks to the global pharmaceutical industry. Their facilities are designed for complex organic synthesis, including high-pressure reactions and specialized chemical processes. The company serves as a critical link in the pharmaceutical supply chain, providing high-purity precursors for essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Zhanhua Haohan Pharmaceutical.